• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CARDIOVASCULAR SYSTEMS CORPORATION NS FX25RWC W/RES; BLOOD GAS OXYGENATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CARDIOVASCULAR SYSTEMS CORPORATION NS FX25RWC W/RES; BLOOD GAS OXYGENATOR Back to Search Results
Model Number 3ZZ*FX25RWCA
Device Problem Device Operates Differently Than Expected (2913)
Patient Problem Blood Loss (2597)
Event Date 07/17/2017
Event Type  Injury  
Manufacturer Narrative
Terumo has received the device for evaluation; however, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.For this reason, terumo references evaluation conclusion code.(b)(4).Results: results pending completion of evaluation.Conclusions: conclusion not yet available-evaluation in progress.
 
Event Description
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, the oxygenator failed.The user facility reported to terumo cardiovascular systems corporation that during cardiopulmonary bypass, the oxygenator failed.When the perfusionist first went on bypass to complete a cabg x 2, the venous saturation was ~78% and then dropped to ~68% after approximately one minute.It was noticed that the blood exiting the oxygenator was dark, and not a bright red color.The gas line connection to the oxygenator was checked and confirmed to have air flow through the line.A line from an oxygen tank was then connected directly to the oxygenator at ~8 lpm, and the blood color became slightly brighter, but not substantially.The perfusionist then filled the heart with the blood from the reservoir and went off bypass.The patient was stable and able to support their own cardiac output.The perfusionist moved the oxygen line from the electronic blender to a standalone blender and went back on bypass; still the blood was not a bright red.The gas out port for air was examined, and not a lot of air was felt exiting the device.It was then decided that the entire circuit would be changed out rather than just the oxygenator as the patient was stable and able to support herself.The change out took approximately 10 minutes.Bypass was initiated on the new circuit and immediately it was noticed that the arterial blood was turning bright red.The venous oxygen saturation % was rising and in the appropriate range for bypass.Surgery was completed successfully without any further issues.No known harm to the patient.Product was changed out.Blood loss amount of 250ml.Delay for 10 minutes.Procedure was completed successfully.
 
Manufacturer Narrative
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on august 7, 2017.(b)(4).Visual inspection of the received sample did not find any anomaly, such as break in the appearance.The sample was tested for its gas transfer performance in accordance to the factory's shipping inspections protocol.No anomalies were revealed in the gas transfer performance of the actual sample, with the obtained values meeting the factory specifications.A definitive root cause could not be determined; therefore, this complaint is not confirmed.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NS FX25RWC W/RES
Type of Device
BLOOD GAS OXYGENATOR
Manufacturer (Section D)
TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
125 blue ball road
elkton MD 21921
Manufacturer Contact
cathleen hargreaves
125 blue ball road
elkton, MD 21921
8002837866
MDR Report Key6772055
MDR Text Key82006627
Report Number1124841-2017-00167
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K151791
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 09/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/07/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/31/2020
Device Model Number3ZZ*FX25RWCA
Device Catalogue NumberN/A
Device Lot NumberVC27
Other Device ID Number(01)00699753450820
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/20/2017
Is the Reporter a Health Professional? No
Date Manufacturer Received08/22/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/28/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-